Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Stock Traders Daily
Provider: New Constructs, LLC
Provider: Jefferson Research

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Albany Molecular Research Inc to Acquire Oso Biopharmaceuticals Manufacturing

Monday, 2 Jun 2014 08:30am EDT 

Albany Molecular Research Inc:Signed a definitive agreement to acquire all of the outstanding membership interests of Oso Biopharmaceuticals Manufacturing, LLC (OsoBio).It is for $110 million in cash.OsoBio is a contract manufacturer of injectable drug products, including sterile liquid, suspension and lyophilized formulations.The acquisition and associated fees are expected to be financed through cash held by AMRI.It is expected to be completed in the third quarter of 2014. 

Company Quote

0.44 +2.90%
26 Dec 2014